Author Correction: Next generation of anti-PD-L1 Atezolizumab with enhanced anti-tumor efficacy in vivo

• Maohua Li,
• Rongqing Zhao,
• Jianxin Chen,
• Wenzhi Tian,
• Chenxi Xia,
• Xudong Liu,
• Yingzi Li,
• Song Li,
• Hunter Sun,
• Tong Shen,
• Wenlin Ren,
• Le Sun

Affiliations

Maohua Li

AbMax BioPharmaceuticals Co., LTD

Rongqing Zhao

AnyGo Technology Co., LTD

Jianxin Chen

ZhenGe Biotechnology Co., LTD

Wenzhi Tian

ImmuneOnco Biopharma (Shanghai) Co., LTD

Chenxi Xia

AbMax BioPharmaceuticals Co., LTD

Xudong Liu

AbMax BioPharmaceuticals Co., LTD

Yingzi Li

AbMax BioPharmaceuticals Co., LTD

Song Li

ImmuneOnco Biopharma (Shanghai) Co., LTD

Hunter Sun

AnyGo Technology Co., LTD

Tong Shen

AbMax BioPharmaceuticals Co., LTD

Wenlin Ren

AbMax BioPharmaceuticals Co., LTD

Le Sun

AbMax BioPharmaceuticals Co., LTD